[1]
Bhella, S. 2023. Chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma: The evolving Canadian landscape. Canadian Hematology Today. 2, 3 (Nov. 2023), 33–38. DOI:https://doi.org/10.58931/cht.2023.2342.